Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
8247cov1_scans.jpg

November 22, 2004 Cover

Volume 82, Issue 47

Because of its complexity, this set of disorders teems with opportunities for drug development, but regulatory criteria for therapeutic outcomes are still lacking

Full Article
Volume 82 | Issue 47

All Issues

Pharmaceuticals

Metabolic Syndrome

Because of its complexity, this set of disorders teems with opportunities for drug development, but regulatory criteria for therapeutic outcomes are still lacking

  • Stradivari's Legacy

    Chemical Analysis Takes On The Cremonese Masters

  • Battening down Cyberspace

    As the government struggles for a foothold, chemical makers develop a strategy

  • Campus Hazard

    EPA finds waste violations at universities, works with schools to tailor rules aimed at industry

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT